Right ventricular dysfunction and the incidence of implantable cardioverter-defibrillator therapies

PACE - Pacing and Clinical Electrophysiology

Volumn 32, Issue 12, 2009, Pages 1501-1508

  Aktas, Mehmet K ^a   Kim, David D ^a   McNitt, Scott ^a   Huang, David T ^a   Rosero, Spencer Z ^a   Hall, Burr W ^a   Zareba, Wojciech ^a   Daubert, James P ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Implantable cardioverter defibrillator; Right ventricular dysfunction; Sudden cardiac death

Indexed keywords

AGED; ARTICLE; CLINICAL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; DEFIBRILLATOR; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE FUNCTION; HUMAN; INCIDENCE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREDICTOR VARIABLE; PRIMARY PREVENTION; QUALITATIVE ANALYSIS; RETROSPECTIVE STUDY; SUDDEN DEATH; SYSTOLE;

AGED; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STROKE VOLUME; SYSTOLE; VENTRICULAR DYSFUNCTION, RIGHT; VENTRICULAR FUNCTION, RIGHT;

EID: 70449707230     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2009.02507.x     Document Type: Article

References (29)

1. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005 352 : 225 237.
2. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999 341 : 1882 1890.
3. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002 346 : 877 883.
4. Buxton AE. Identifying the high risk patient with coronary artery disease - Is ejection fraction all you need? J Cardiovasc Electrophysiol 2005 16 (Suppl. 1 S25 S27.
5. Gehi A, Haas D, Fuster V. Primary prophylaxis with the implantable cardioverter-defibrillator: The need for improved risk stratification. JAMA 2005 294 : 958 960.
6. Singh JP, Hall WJ, McNitt S, Wang H, Daubert JP, Zareba W, Ruskin JN, et al. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: Findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). J Am Coll Cardiol 2005 46 : 1712 1720.
7. Mehta SR, Eikelboom JW, Natarajan MK, Diaz R, Yi C, Gibbons RJ, Yusuf S. Impact of right ventricular involvement on mortality and morbidity in patients with inferior myocardial infarction. J Am Coll Cardiol 2001 37 : 37 43.
8. Zornoff LA, Skali H, Pfeffer MA, St John Sutton M, Rouleau JL, Lamas GA, Plappert T, et al. Right ventricular dysfunction and risk of heart failure and mortality after myocardial infarction. J Am Coll Cardiol 2002 39 : 1450 1455.
9. de Groote P, Millaire A, Foucher-Hossein C, Nugue O, Marchandise X, Ducloux G, Lablanche JM. Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure. J Am Coll Cardiol 1998 32 : 948 954.
10. Di Salvo TG, Mathier M, Semigran MJ, Dec GW. Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll Cardiol 1995 25 : 1143 1153.
11. Sanders GD, Hlatky MA, Owens DK. Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med 2005 353 : 1471 1480.
12. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 2006 48 : e247 e346.
13. McClellan MB, Tunis SR. Medicare coverage of ICDs. N Engl J Med 2005 352 : 222 224.
14. Chen HA, Hsia HH, Vagelos R, Fowler M, Wang P, Al-Ahmad A. The effect of gender on mortality or appropriate shock in patients with nonischemic cardiomyopathy who have implantable cardioverter-defibrillators. Pacing Clin Electrophysiol 2007 30 : 390 394.
15. Daubert JP, Zareba W, Hall WJ, Schuger C, Corsello A, Leon AR, Andrews ML, et al. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. J Am Coll Cardiol 2006 47 : 98 107.
16. Myles RC, Jackson CE, Tsorlalis I, Petrie MC, McMurray JJ, Cobbe SM. Is microvolt T-wave alternans the answer to risk stratification in heart failure? Circulation 2007 116 : 2984 2991.
17. Vorobiof G, Goldenberg I, Moss AJ, Zareba W, McNitt S. Effectiveness of the implantable cardioverter defibrillator in blacks versus whites (from MADIT-II). Am J Cardiol 2006 98 : 1383 1386.
18. Goldenberg I, Vyas AK, Hall WJ, Moss AJ, Wang H, He H, Zareba W, et al. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 2008 51 : 288 296.
19. Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webb-Peploe KM, Harrington D, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 1997 349 : 1050 1053.
20. Gomez JF, Zareba W, Moss AJ, McNitt S, Hall WJ. Prognostic value of location and type of myocardial infarction in the setting of advanced left ventricular dysfunction. Am J Cardiol 2007 99 : 642 646.
21. Mahenthiran J, Das MK, Bhakta D, Ghumman W, Feigenbaum H, Sawada SG. Prognostic importance of wall motion abnormalities in patients with ischemic cardiomyopathy and an implantable cardioverter-defibrillator. Am J Cardiol 2006 98 : 1301 1306.
22. Luu M, Stevenson WG, Stevenson LW, Baron K, Walden J. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation 1989 80 : 1675 1680.
23. Hunt GB, Ross DL. Right versus left ventricular stimulation: Influence on induction of ventricular tachyarrhythmias in dogs. Int J Cardiol 1990 28 : 317 324.
24. Callans DJ, Josephson ME. Ventricular tachycardia in patients with coronary artery disease. In : Zipes DP, Jalife J (eds. Cardiac Electrophysiology: From Cell to Bedside, 4th ed. Philadelphia, WB Saunders, 2004, pp. 569 574.
25. Galvin JM, Ruskin JN. Ventricular tachycardia in patients with dilated cardiomyopathy. In : Zipes DP, Jalife J (eds. Cardiac Electrophysiology: From Cell to Bedside, 4th ed. Philadelphia, WB Saunders, 2004, pp. 575 587.
26. Gottdiener JS, Bednarz J, Devereux R, Gardin J, Klein A, Manning WJ, Morehead A, et al. American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr 2004 17 : 1086 1119.
27. Meluzin J, Spinarova L, Hude P, Krejci J, Kincl V, Panovsky R, Dusek L. Prognostic importance of various echocardiographic right ventricular functional parameters in patients with symptomatic heart failure. J Am Soc Echocardiogr 2005 18 : 435 444.
28. Anavekar NS, Skali H, Bourgoun M, Ghali JK, Kober L, Maggioni AP, McMurray JJ, et al. Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO Study). Am J Cardiol 2008 101 : 607 612.
29. Walsh TF, Hundley WG. Assessment of ventricular function with cardiovascular magnetic resonance. Cardiol Clin 2007 25 : 15 33, v.